tiprankstipranks
Assertio Therapeutics (ASRT)
NASDAQ:ASRT
US Market
ASRT
Assertio Therapeutics
RESEARCH TOOLSreports
Want to see ASRT full AI Analyst Report?

Assertio Therapeutics (ASRT) Stock News & Sentiment

1,164 Followers
Assertio Therapeutics to be acquired by Zydus Worldwide
Premium
Company Announcements
Assertio Therapeutics to be acquired by Zydus Worldwide
3d ago
8K
ASRT
Assertio Therapeutics to Be Acquired by Zydus Worldwide
Premium
Company Announcements
Assertio Therapeutics to Be Acquired by Zydus Worldwide
8d ago
8K
ASRT
Assertio Therapeutics’ Cosette Divestiture Leaves Material Legacy Liabilities and Indemnification Risks That Could Pressure Cash Flow and Valuation
Premium
Company Announcements
Assertio Therapeutics’ Cosette Divestiture Leaves Material Legacy Liabilities and Indemnification Risks That Could Pressure Cash Flow and Valuation
11d ago
ASRT
ASRT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ASRT Earnings this Week: How Will it Perform?
12d ago
ASRT
Assertio Extends Deadline for Garda Acquisition Tender Offer
Premium
Company Announcements
Assertio Extends Deadline for Garda Acquisition Tender Offer
13d ago
8K
ASRT
Naz Rahman Reiterates Hold on Assertio as Garda Boosts All‑Cash Tender Offer to $21.80 Per Share
Premium
Ratings
Naz Rahman Reiterates Hold on Assertio as Garda Boosts All‑Cash Tender Offer to $21.80 Per Share
16d ago
ASRT
Assertio Delays Tender Offers in Pending Garda Acquisition
Premium
Company Announcements
Assertio Delays Tender Offers in Pending Garda Acquisition
16d ago
8K
ASRT
More ASRT News >

ASRT News on the Web

Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Therapeutics (ORKA)
TipRanks News
Neutral
Assertio to be acquired by Zydus Worldwide DMCC for $23.50 per share
TipRanks News
Bullish
Assertio price target raised to $23.50 from $21.80 at Lake Street
TipRanks News
Bullish
Assertio Therapeutics to Be Acquired by Zydus Worldwide
TipRanks News
Neutral
Assertio Terminates Garda Agreement, Agrees To $166.4 Mln Acquisition By Zydus Worldwide DMCC
rttnews
Bullish
Assertio Shareholders to Benefit from 75.8% Premium in Zydus All-Cash Acquisition
Market Chameleon
Neutral
Zydus Acquisition Offer for Assertio Delivers 75.8% Premium Over Unaffected Price—Here’s What Investors Need to Know
Market Chameleon
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Cencora (COR), LeonaBio (LONA) and Assertio Therapeutics (ASRT)
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
ASRT
Sector Average
Media Buzz
This Week1 articles
Weekly Average6.25 articles
News Sentiment
This Week59%
Sector Average76%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ASRT’s Media Buzz Sentiment?
1 articles about ASRT were published this week. In an average week, 6.25 articles are published.
    What is ASRT’s weekly average amount of articles?
    In an average week, 6.25 articles about ASRT are published.
      What is ASRT’s News Sentiment?
      59% of articles about ASRT were positive this week, compared to its sector average of 76%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        PROKProKidney
        Showing the stocks with the most bullish news sentiment over the past week